Im interested in purchasing more than one cell line from the NIH Stem Cell Registry. What is known about the status of the cell lines and their availability?
Many of the cell lines have been characterized as embryonic stem cells by detecting expression of surface antigen markers specific to embryonic stem cells, determining if the cells are pluripotent, and demonstrate that the cells are undifferentiated. A number of scientific publications have described the characterization of human embryonic stem cells. Providers of the federally eligible cells are working to make them available to researchers. This includes developing quality control measures to grow and reproduce the cell lines in sufficient numbers, having the administrative structure to receive and process requests, and establishing material transfer agreements with research purchasers. The providers of federally eligible cell lines have the most up-to-date information on availability. A list of these sources and contact information is available on the NIH Stem Cell Registry[1].
Related Questions
- Im interested in purchasing more than one cell line from the NIH Stem Cell Registry. What is known about the status of the cell lines and their availability?
- Once a human embryonic stem cell line is listed on the NIH Human Embryonic Stem Cell Registry, are lines derived from it also eligible?
- Are there any restrictions on the use of lines listed on the NIH Human Embryonic Stem Cell Registry?
